6533b838fe1ef96bd12a4ffb

RESEARCH PRODUCT

Comparative study of the osteogenic potential of mesenchymal stem cells derived from different sources

Iman M. AboushadyZeinab A. SalemAbbas MohamedDina Sabry

subject

0301 basic medicineCell typeOral Medicine and PathologySalivary glandResearchMesenchymal stem cellProliferation assayBiology:CIENCIAS MÉDICAS [UNESCO]Bone tissueStain03 medical and health sciences030104 developmental biologymedicine.anatomical_structurestomatognathic systemProliferation rateUNESCO::CIENCIAS MÉDICASCancer researchmedicineBone marrowGeneral Dentistry

description

Background Mesenchymal stem cells (MSCs) can regenerate missing tissues and treat diseases. Hence, the current work aimed to compare the proliferation rate and the osteogenic differentiation potential of bone marrow MSCs (BMSCs), gingival MSCs (GMSCs) and submandibular MSCs (SMSCs). Material and Methods MSCs derived from bone marrow, gingiva and submandibular salivary gland were isolated and cultured from rats. The proliferation capacity was judged by MTT proliferation Assay. Osteogenic differentiation was assessed by Alzarin red stain and quantitative RT-PCR was performed for Runx-2 and MMP-13. Results The highest significant proliferation was estimated in the BMSCs compared to GMSCs and SMSCs (p-value was < 0.01). All studied cell types formed mineralized nodules as stained with Alizarin Red stain at the 3rd passage of differentiation. However, BMSCs seemed to generate the highest level of mineralization compared to GMSCs and SMSCs. RT-PCR revealed that the expression of Runx-2 and MMP-13 mRNAs was significantly increased in the BMSCs compared to GMSCs and SMSCs (p-value was < 0.01). Conclusions BMSCs displayed maximum osteogenesis results followed by the GMSCs and lastly by the SGSCs. Thus, it could be recommended that GMSCs can be used as a second choice after BMSCs when bone tissue reconstruction is needed. Key words:Mesenchymal stem cells, osteogenic differentiation, Runx-2, MMP-13.

https://doi.org/10.4317/jced.53957